ANDREUCCI, Michele
 Distribuzione geografica
Continente #
NA - Nord America 5.190
AS - Asia 3.988
EU - Europa 1.841
SA - Sud America 1.159
Continente sconosciuto - Info sul continente non disponibili 275
AF - Africa 109
OC - Oceania 16
AN - Antartide 1
Totale 12.579
Nazione #
US - Stati Uniti d'America 4.991
SG - Singapore 1.801
BR - Brasile 899
IT - Italia 879
CN - Cina 800
VN - Vietnam 558
IN - India 332
DE - Germania 203
GB - Regno Unito 190
BD - Bangladesh 119
HK - Hong Kong 118
CA - Canada 106
SE - Svezia 106
AR - Argentina 101
FI - Finlandia 89
NL - Olanda 64
UA - Ucraina 62
MX - Messico 58
FR - Francia 46
ID - Indonesia 46
EC - Ecuador 44
ZA - Sudafrica 39
IQ - Iraq 38
CO - Colombia 34
ES - Italia 32
RU - Federazione Russa 32
JP - Giappone 28
RO - Romania 28
CL - Cile 27
PL - Polonia 24
TR - Turchia 18
UZ - Uzbekistan 18
EG - Egitto 16
IR - Iran 15
PK - Pakistan 15
PY - Paraguay 15
AU - Australia 13
VE - Venezuela 13
AT - Austria 12
MA - Marocco 12
PE - Perù 12
TN - Tunisia 12
GR - Grecia 11
SA - Arabia Saudita 11
CZ - Repubblica Ceca 9
KE - Kenya 9
UY - Uruguay 9
TH - Thailandia 8
CH - Svizzera 7
JO - Giordania 7
RS - Serbia 7
DO - Repubblica Dominicana 6
JM - Giamaica 6
KZ - Kazakistan 6
LT - Lituania 6
TW - Taiwan 6
KR - Corea 5
NG - Nigeria 5
SV - El Salvador 5
A2 - ???statistics.table.value.countryCode.A2??? 4
AL - Albania 4
BO - Bolivia 4
EU - Europa 4
LB - Libano 4
MY - Malesia 4
SI - Slovenia 4
AO - Angola 3
BN - Brunei Darussalam 3
CR - Costa Rica 3
ET - Etiopia 3
HN - Honduras 3
IE - Irlanda 3
KG - Kirghizistan 3
KW - Kuwait 3
LV - Lettonia 3
MK - Macedonia 3
OM - Oman 3
PA - Panama 3
PH - Filippine 3
PR - Porto Rico 3
PT - Portogallo 3
SY - Repubblica araba siriana 3
AE - Emirati Arabi Uniti 2
BB - Barbados 2
BG - Bulgaria 2
CY - Cipro 2
DZ - Algeria 2
EE - Estonia 2
IL - Israele 2
LU - Lussemburgo 2
NI - Nicaragua 2
NP - Nepal 2
NZ - Nuova Zelanda 2
SC - Seychelles 2
AM - Armenia 1
AQ - Antartide 1
AZ - Azerbaigian 1
BE - Belgio 1
BH - Bahrain 1
BS - Bahamas 1
Totale 12.294
Città #
San Jose 924
Singapore 632
Dallas 516
Ashburn 422
Chandler 378
Santa Clara 321
Bengaluru 262
Hefei 261
Milan 232
Council Bluffs 216
Ho Chi Minh City 210
Lawrence 191
Princeton 191
London 130
Chicago 129
Munich 128
Beijing 119
Hanoi 116
Wilmington 115
Hong Kong 109
São Paulo 77
Turku 62
Los Angeles 60
Boardman 59
Catanzaro 58
Des Moines 56
New York 54
Ottawa 54
Rome 33
Shanghai 30
Rio de Janeiro 29
Helsinki 26
Naples 26
Haiphong 25
Amsterdam 24
Palermo 24
Boydton 23
Brooklyn 23
Norwalk 23
Da Nang 20
Thái Bình 20
Bari 19
Boston 18
Redwood City 18
Johannesburg 17
San Francisco 17
Tashkent 17
Baghdad 16
Guayaquil 16
Orem 16
Tokyo 16
Warsaw 16
Chennai 15
Guarulhos 15
Mexico City 15
Biên Hòa 14
Florence 14
Quito 14
Redmond 14
Ninh Bình 13
Porto Alegre 13
Bologna 12
Guangzhou 12
Montreal 12
Toronto 12
Verona 12
Atlanta 11
Buffalo 11
Crotone 11
Dhaka 11
Hanover 11
Manchester 11
Phoenix 11
Seattle 11
Timisoara 11
Assago 10
Curitiba 10
Lima 10
Mumbai 10
Belo Horizonte 9
Brasília 9
Columbus 9
Hải Dương 9
Medellín 9
Nairobi 9
Pescara 9
Pune 9
Sydney 9
The Dalles 9
Bogotá 8
Campinas 8
Catania 8
Erbil 8
Jakarta 8
Manaus 8
Salvador 8
Shenzhen 8
Shibin al Kawm 8
Stockholm 8
Wuhan 8
Totale 7.098
Nome #
Urinary Marinobufagenin in Patients with Non-Advanced Chronic Kidney Disease: A Cross-Sectional Study 129
The Shaggy Aorta Syndrome: an updated review 129
Antecedent ACE-inhibition, inflammatory response, and cardiac surgery associated acute kidney injury 119
Bridging Biology and Society: Molecular Insights into Social Determinants of Vascular Disease 108
Elevati livelli del “marker” tumorale Ca-125 nei pazienti con sindrome nefrosica 102
Role of a dual glucose-dependent insulinotropic peptide (GIP)/glucagon-like peptide-1 receptor agonist (twincretin) in glycemic control: From pathophysiology to treatment 99
Risk of Bleeding in Elderly Patients Undergoing Transcatheter Aortic Valve Implantation or Surgical Aortic Valve Replacement 96
Genetic biomarkers in chronic venous disease 90
Hypoxia-inducible factor stabilizers in end stage kidney disease: “can the promise be kept?” 89
Ankle-Brachial Index evaluation in totally percutaneous approach vs. femoral artery cutdown for endovascular aortic repair of abdominal aortic aneurysms 88
Altered circulating marinobufagenin levels and recurrent intradialytic hypotensive episodes in chronic hemodialysis patients: a pilot, prospective study 88
#4500 IMPLEMENTATION OF A NEW GENERATION DIGITAL STETHOSCOPE FOR ARTERIOVENOUS FISTULA MONITORING IN HEMODIALYSIS PATIENTS 84
A Rare Complication of Ascariasis: A Case of Acute Interstitial Nephritis 84
Aortic Aneurysms, Chronic Kidney Disease and Metalloproteinases 81
Quality of life, clinical outcome, personality and coping in chronic hemodialysis patients 79
Cathepsin-K is a potential cardiovascular risk biomarker in prevalent hemodialysis patients 78
A portable easy-to-use triboelectric sensor for arteriovenous fistula monitoring in dialysis patients 75
Efficacy and Safety of Jotec E-Ventus BX Stent Graft for Iliac Branch Device Procedure: A Retrospective Clinical Study 75
An open-label, randomized, placebo-controlled study on the effectiveness of a novel probiotics administration protocol (ProbiotiCKD) in patients with mild renal insufficiency (stage 3a of CKD) 74
Biomarkers and Social Determinants in atherosclerotic Arterial Diseases: A Scoping Review 73
Evaluation of arteriovenous fistula for hemodialysis with a new generation digital stethoscope: a pilot study 73
Glomerular and tubular effects of dapagliflozin, eplerenone and their combination in patients with chronic kidney disease: A post-hoc analysis of the ROTATE-3 study 73
LOW CIRCULATING LEVELS OF CARDIO-REGULATORY MIRNAS PREDICT WORSE OUTCOMES IN HEMODIALYSIS PATIENTS 73
Role of proteinuria in clinical research: For each old-answer, a new key-question 73
An uncommon presentation of an uncommon nephropathy: the karyomegalic interstitial nephritis 71
Acquisition of optical coherence tomography angiography metrics during hemodialysis procedures: A pilot study 70
Albuminuria-Lowering Effect of Dapagliflozin, Eplerenone, and their Combination in Patients with Chronic Kidney Disease: A Randomized Cross-over Clinical Trial 69
Epidemiology of cardiovascular risk in chronic kidney disease patients: the real silent killer 69
Circulating Omentin-1 levels and altered iron balance in chronic haemodialysis patients 69
A small circulating miRNAs signature predicts mortality and adverse cardiovascular outcomes in chronic hemodialysis patients 67
L'insufficienza renale acuta tossico-ischemica 66
Role of metalloproteinases and their inhibitors in the development of abdominal aortic aneurysm: current insights and systematic review of the literature 66
Differential activation of signaling pathways involved in cell death, survival and inflammation by radiocontrast media in human renal proximal tubular cells 66
Omics in chronic kidney disease: Focus on prognosis and prediction 66
Autosomic dominant polycystic kidney disease and metformin: Old knowledge and new insights on retarding progression of chronic kidney disease 66
Hyperkalemia in CKD: an overview of available therapeutic strategies 66
Role of Vitamin K in Chronic Kidney Disease: A Focus on Bone and Cardiovascular Health 66
The Mitochondrial-Derived Peptide MOTS-c May Refine Mortality and Cardiovascular Risk Prediction in Chronic Hemodialysis Patients: A Multicenter Cohort Study 65
Iron Infusion And Induced Hypophosphatemia: The Role Of FGF2 65
Clinical and Pathological Correlations in Chronic Venous Disease 65
#4524 TRIBOELECTRIC EVALUATION OF ARTERIOVENOUS FISTULA FOR HAEMODIALYSIS: A PILOT STUDY 64
Atorvastatin improves the course of ischemic acute renal failure in aging rats 64
Anemia and Mineral Bone Disorder in Kidney Disease Patients: The Role of FGF-23 and Other Related Factors 63
Novel biomarkers for cardiovascular risk 63
Neutrophil-to-lymphocyte Ratio and Platelet-to-lymphocyte Ratio as Biomarkers for Cardiovascular Surgery Procedures: A Literature Review 63
Workplace Violence towards Healthcare Workers: An Italian Cross-Sectional Survey 63
A Qualitative Study on the Role of Social Determinants of Health in Patients with Peripheral Artery Disease 62
New Insights on the Role of Marinobufagenin from Bench to Bedside in Cardiovascular and Kidney Diseases 61
Social Aspects of Diabetic Foot: A Scoping Review 60
Additive antiproteinuric effect of converting enzyme inhibitor and losartan in normotensive patients with IgA nephropathy 59
Antiproteinuric effect of DPP-IV inhibitors in diabetic and non-diabetic kidney diseases 59
Assessment of androgen receptor, IGF-IR and insulin receptor expression in male patients with severe peripheral artery disease 59
Insomnia Prevalence among Italian Night-Shift Nurses 59
Nephrosclerosis impacts time trajectory of renal function and outcomes in elderly individuals with chronic kidney disease 59
Development of a Wearable Device for Arteriovenous Fistula Monitoring 58
Anti-renin-angiotensin-system drugs and development of anemia in chronic kidney disease 58
Association between Inguinal Hernia and Arterial Disease: A Preliminary Report 58
Retarding progression of chronic kidney disease in autosomal dominant polycystic kidney disease with metformin and other therapies: An update of new insights 58
Circulating Omentin-1, Sustained Inflammation and Hyperphosphatemia at the Interface of Subclinical Atherosclerosis in Chronic Kidney Disease Patients on Chronic Renal Replacement Therapy 58
Endovenous radiofrequency ablation of tributary veins reflux 57
Contribution of Predictive and Prognostic Biomarkers to Clinical Research on Chronic Kidney Disease 57
Very low urinary marinobufagenin excretion reflects a high risk of disease progression in non-advanced CKD 56
Can the aggravation of pruritus be a sign of worsening peripheral neuropathy in uremic disease? A clinical and Neurophysiological study 56
Role of renal biopsy in the diagnosis and prognosis of acute renal failure 56
P1422CATHEPSIN-K IS A POWERFUL DIAGNOSTIC BIOMARKER IN PARATHYROIDECTOMIZED DIALYSIS PATIENTS 56
Novel biomarkers in cardiovascular surgery 56
Marinobufagenin, left ventricular geometry and cardiac dysfunction in end-stage kidney disease patients 56
Renal hemodynamic response to maximal vasodilating stimulus in healthy older subjects 55
Functional chronic venous disease: A systematic review 55
Radiographic contrast nephropathy 55
Cardiovascular disease as a biomarker for an increased risk of COVID-19 infection and related poor prognosis 55
Downregulation of cell survival signalling pathways and increased cell damage in hydrogen peroxide-treated human renal proximal tubular cells by alpha-erythropoietin 55
Can Pulsatile Cardiopulmonary Bypass Prevent Perioperative Renal Dysfunction during Myocardial Revascularization in Elderly Patients? 54
Increased circulating Cathepsin-K levels reflect PTH control in chronic hemodialysis patients 54
Work and the Veins. A Retrospective Analysis of Work Activities in Patients with Chronic Venous Disease 53
Diuretics in renal failure. 52
New-onset hemodialysis-related headache presenting as migraine aura 52
BIOMARKERS FOR PRECISION MEDICINE IN PHLEBOLOGY AND WOUND CARE. A SYSTEMATIC REVIEW 52
P1417ALTERED CATHEPSIN-K LEVELS REFLECT SEVERITY OF MINERAL BONE DISEASE AND INFLAMMATION IN CHRONIC HEMODIALYSIS PATIENTS 52
OCT angiography metrics predict intradialytic hypotension episodes in chronic hemodialysis patients: a pilot, prospective study 52
Elevate to Alleviate – Evidence Based Vascular Nursing Study 52
Childhood Obesity: Insight into Kidney Involvement 51
Selenoprotein P-1 (SEPP1) as an Early Biomarker of Acute Kidney Injury in Patients Undergoing Cardiopulmonary Bypass 51
Anderson-Fabry's disease: diagnostic problems, therapeutic relevance, and clinical experience in the treatment of the disease with enzyme replacement therapy in nephropathic patients 51
Th17-Gene Expression Profile in Patients with Chronic Venous Disease and Venous Ulcers: Genetic Modulations and Preliminary Clinical Evidence 50
Is erythropoietin always cytoprotective? 50
Effect of paricalcitol vs calcitriol on hemoglobin levels in chronic kidney disease patients: a randomized trial. 50
Sympathovagal balance and 1-h postload plasma glucose in normoglucose tolerant hypertensive patients 50
Vasomotor nephropathy in the elderly 50
Sodium-Glucose Co-transporter-2 Inhibitors and Nephroprotection in Diabetic Patients: More Than a Challenge 50
Darbepoetin alfa reduces cell death due to radiocontrast media in human renal proximal tubular cells 50
Understanding Vascular Calcification in Chronic Kidney Disease: Pathogenesis and Therapeutic Implications 49
Competitive interaction between smoking and chronic obstructive pulmonary disease for explaining renal function reduction in hypertensive patients 49
Potential Pathogenetic Role of the D313Y Mutation in the GLA Gene in Anderson Fabry Disease: Two Case Reports 49
Can young adult patients with proteinuric IgA nephropathy perform physical exercise? 49
Serum Alkaline Phosphatase Negatively Affects Endothelium-Dependent Vasodilation in Naïve Hypertensive Patients. 49
Renal resistive index in chronic kidney disease patients: Possible determinants and risk profile 49
Unraveling Cardiovascular Risk in Renal Patients: A New Take on Old Tale 49
Metalloproteinases in Cardiac Surgery: A Systematic Review 48
Urinary Post-Translationally Modified Fetuin-A (uPTM-FetA) in Chronic Kidney Disease Patients with and without Diabetic Kidney Disease 48
Totale 6.492
Categoria #
all - tutte 122.206
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 122.206


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022554 0 8 20 96 32 7 36 142 46 58 100 9
2022/20231.316 391 129 42 109 80 80 20 94 186 67 87 31
2023/2024850 144 105 56 61 55 183 29 56 38 22 42 59
2024/20252.576 370 131 114 113 115 370 69 77 273 181 286 477
2025/20266.577 305 702 934 1.360 604 218 624 391 707 427 144 161
2026/2027311 59 252 0 0 0 0 0 0 0 0 0 0
Totale 12.579